GLP-1 Before Colonoscopy: Should You Stop Ozempic, Wegovy, Mounjaro, or Zepbound?
Published: · Last reviewed:
The bottom line
The October 2024 multi-society guidance — endorsed by anesthesiologists, gastroenterologists, and bariatric surgeons — says most adults on a stable GLP-1 with no stomach symptoms can keep taking their medication before an elective colonoscopy, usually with a 24-hour clear liquid diet. But the ASGE 2025 position statement recommends holding daily GLP-1s for at least 24 hours and weekly GLP-1s for at least 7 days. Many GI offices follow the stricter ASGE rule. The facility doing your colonoscopy controls the day-of decision. Always confirm with your prescribing clinician before changing a diabetes medication.
🚨 If your colonoscopy is within 7 days and you take a weekly GLP-1
Stop reading and call the endoscopy center now. Don't take your next dose until you have guidance. Don't hide that you already took it if you did.
The 30-Second Decision Table
If you remember nothing else from this page, remember this:
| Your situation | What likely happens | What to do right now |
|---|---|---|
| Stable maintenance dose. No nausea, vomiting, bloating, or constipation. Routine screening colonoscopy. | The 2024 multi-society guidance supports continuing with a 24-hour clear liquid diet. ASGE-aligned facilities may still require a hold. | Follow the prep packet from the facility. If it doesn’t mention GLP-1s, call and tell them which one you take. |
| You take a weekly GLP-1 (Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity) and your procedure is within 7 days. | Many endoscopy centers use a 7-day hold policy aligned with ASGE’s 2025 position statement. | Call before you take your next dose. |
| You already took your weekly dose this week. | The plan depends on your symptoms, your facility, and your sedation plan. | Call the endoscopy center now. Don’t hide it. |
| You have nausea, vomiting, fullness, abdominal pain, severe constipation, or diagnosed gastroparesis. | You’re in the higher-risk group. The team may add a clear liquid diet, change anesthesia, or reschedule. | Call the endoscopy center early — at least several days before prep. |
| You take a GLP-1 for diabetes plus insulin or a sulfonylurea (like glipizide or glyburide). | Holding the GLP-1 plus a clear liquid prep can swing blood sugar in either direction. | Call the prescriber who manages your diabetes for a glucose plan. |
| Your colonoscopy is combined with an upper endoscopy (EGD). | The stomach gets directly examined and the aspiration conversation matters more. | Tell anesthesia which GLP-1 you’re on, when your last dose was, and any symptoms. |
What We Verified for This Page
Sources verified — · Next review: August 2026
We read the original text of the five current guidance documents on GLP-1 use before endoscopy, plus FDA labels for six products and five bowel-prep evidence sources. We did not invent any hold timing or evidence statistics.
Why Are You Getting Conflicting GLP-1 Colonoscopy Instructions?
The science moved fast and the guidance moved with it — but not all at once and not in the same direction. Today there are five major guidance documents on GLP-1 use before endoscopy, and they don't all say the same thing. Different specialty societies emphasize different risks. Local endoscopy centers often use the strictest version. That's why your prep packet from one office can disagree with a friend's prep packet from another.
The ASA put out consensus-based guidance saying anyone on a GLP-1 should hold daily formulations the day of the procedure and weekly formulations for a week before any elective procedure or surgery. That rule applied regardless of indication, dose, or procedure type. If you took the dose anyway, you were treated as a “full stomach” patient. This is the rule a lot of clinics printed onto their prep sheets. A lot of those sheets are still in use.
A few months later, a multi-society GI statement said there was little or no data on the relative risk of aspiration complications, that the impact of stopping GLP-1s before sedated endoscopy was unknown, and that more data were needed.
The AGA pushed back on blanket holds. Their position: if you have no stomach symptoms and you followed standard fasting (no food for 8 hours, no liquids for 2 hours), the procedure could likely proceed.
Five societies agreed on a risk-based approach. Most patients can continue their GLP-1 before elective surgery and elective endoscopy. Higher-risk patients should follow a 24-hour clear liquid diet, may need an anesthesia plan change, and in rare cases may need a delay. If a hold is chosen, the original ASA timing serves as the default.
ASGE released an endoscopy-specific position statement recommending holding daily GLP-1s for at least 24 hours before elective endoscopy and weekly GLP-1s for at least 7 days before. Oral semaglutide (Rybelsus) should be held the day before. This daily-drug timing is stricter than the original ASA 2023 rule. Many GI offices follow this rule — they’re not behind; they’re following their own subspecialty society.
So who is right?
Both can be right. The 2024 multi-society perioperative guidance covers all elective procedures. ASGE's position is endoscopy-specific. Local endoscopy centers can pick whichever rule they think is safest, and many pick the stricter ASGE-aligned policy because the consequence of a bad outcome falls on them. The practical takeaway: the facility doing your colonoscopy controls the day-of decision. Their prep packet wins, even if a different society's guidance disagrees.
The Five-Document Guidance Reconciliation Table
If your prep packet uses a different rule than what your endocrinologist or weight-loss provider told you, this table is why.
| Guidance document | Date | Issuing body | What it says about holding GLP-1s before colonoscopy | Status |
|---|---|---|---|---|
| ASA Consensus-Based Guidance | June 2023 | American Society of Anesthesiologists | Hold daily formulations day-of. Hold weekly formulations 1 week before. Applies to all elective procedures regardless of indication or dose. If not held and no symptoms, treat as "full stomach." | ASA later participated in the Oct 2024 multi-society risk-based guidance, but this 2023 hold rule still appears in many older prep workflows. |
| GI Multi-Society Statement | August 2023 | AASLD, ACG, AGA, ASGE, NASPGHAN | Little or no data on relative aspiration risk; impact of stopping GLP-1s before sedated endoscopy unknown; more data needed. | Active. |
| AGA Rapid Clinical Practice Update | November 2023 | American Gastroenterological Association | Insufficient evidence for blanket holds. Individualize. Proceed as planned for patients with no GI symptoms who followed standard fasting. | Active. Aligns with the Oct 2024 update. |
| Multi-Society Clinical Practice Guidance | October 2024 | AGA + ASMBS + ASA + ISPCOP + SAGES | Most patients can continue GLP-1s before elective procedures. Use shared decision-making. Apply 24-hour clear liquid diet for higher-risk patients. If holding, follow original ASA timing. | Current multi-society perioperative guidance; active alongside ASGE’s 2025 endoscopy-specific position. |
| ASGE Position Statement | 2025 | American Society for Gastrointestinal Endoscopy | Hold daily GLP-1s for at least 24 hours and weekly GLP-1s for at least 7 days before elective endoscopy. Hold oral semaglutide the day before. | Active. Endoscopy-specific. |
The Two Different Risks (and Why Most Pages Mash Them Together)
A GLP-1 before colonoscopy creates two separate worries, not one. The first is aspiration during sedation — food still in your stomach getting into your lungs while you're sedated. The second is a poor bowel prep — stool still in your colon, blocking the doctor's view of polyps and possibly forcing a repeat procedure. These two risks have different evidence, different mitigation strategies, and different teams handling them.
Risk #1 — Anesthesia team's concern
Aspiration during sedation
GLP-1s slow how fast your stomach empties. Even if you've fasted overnight, food and liquid can still be sitting in your stomach when you go under sedation. If your stomach empties slowly enough, that food can come back up and end up in your lungs. This is rare — but it's the reason anesthesiologists started paying attention to GLP-1s in the first place.
FDA label language (Ozempic, Wegovy, Mounjaro, Zepbound)
Postmarketing reports of pulmonary aspiration during procedures requiring general anesthesia or deep sedation. Insufficient evidence to determine whether holding the drug or modifying fasting reduces risk.
Risk #2 — Gastroenterologist's concern
Poor bowel prep
A colonoscopy depends on a clean colon. Because GLP-1s also slow gut motility, prep solutions may not work as well. The result is either a missed polyp or a repeated procedure. Several studies have looked at this with mixed findings:
- Nasser et al., JAMA Network Open 2024: inadequate prep in 21.3% of GLP-1 users vs. 6.5% of controls. No aspiration events.
- Mayo / Gala et al. 2025 (3,344 GLP-1 users, 22 endoscopy units): 26.4% vs. 18.7% inadequate prep.
- Ahmed et al., GIE 2026 (116,174 patients): no statistically significant pooled increase in inadequate prep.
- Chiu et al., DLD 2025: higher inadequate-prep risk in GLP-1 users.
Why this distinction matters for you
Your GI office may be holding the medication to protect bowel prep quality. Your anesthesiologist may be holding it to reduce aspiration risk. You don't have to figure out which one motivated the rule. You just need to know that there are two different conversations, and asking the right question to the right team gets you a better answer.
GLP-1 Before Colonoscopy: Should You Stop It?
Most adults on a stable, maintenance dose with no current GI symptoms can continue under the October 2024 multi-society guidance — usually with a 24-hour clear liquid diet. ASGE-aligned facilities may still require a 7-day hold for weekly drugs and a 24-hour hold for daily drugs. The facility doing your colonoscopy controls the final answer.
Stable weekly GLP-1 (Ozempic, Wegovy Pen, Mounjaro, Zepbound) — no GI symptoms — routine screening
Likely continue with 24-hour clear liquid diet (2024 guidance) OR hold for 7 days (ASGE 2025 / many facilities). Confirm with the facility.
Daily GLP-1 (Rybelsus, Wegovy Pill, Victoza, Saxenda, Byetta) — no GI symptoms
Hold the day before / at least 24 hours before (ASGE 2025), or skip the dose the day of the procedure (ASA 2023). Confirm with the facility.
Just escalated my dose in the last 4–8 weeks
Higher-risk. Discuss a 24-hour liquid diet or a hold with the care team.
I have nausea, vomiting, fullness long after eating, or severe constipation
Higher-risk. Don’t skip the conversation. The procedure may be modified or rescheduled.
My GI office told me to hold for 1–2 weeks and I’m worried about my dose
Follow it, then ask the prescribing clinician for a glucose plan if you have diabetes, or a missed-dose plan otherwise.
How Long to Stop Your Specific GLP-1 Before a Colonoscopy
Hold timing depends on which guidance your facility follows. The table below shows both ASA 2023 and ASGE 2025 timings where they differ. The aspiration warning on FDA labels applies across the GLP-1 class.
| Brand | Generic | Schedule | Hold timing if held | Notes |
|---|---|---|---|---|
| Ozempic | Semaglutide | Weekly injection | 1 week before (ASA 2023 and ASGE 2025) | |
| Wegovy Pen | Semaglutide | Weekly injection | 1 week before (ASA 2023 and ASGE 2025) | Weight-management injection. Usual maintenance 2.4 mg weekly; Wegovy HD 7.2 mg also FDA-approved. |
| Wegovy Pill | Semaglutide | Daily oral tablet | Day before / at least 24 hr before (ASGE 2025) or day of procedure (ASA 2023) | FDA-approved December 2025. Recommended maintenance 25 mg once daily. |
| Rybelsus | Semaglutide | Daily oral tablet | Day before / at least 24 hr before (ASGE 2025) or day of procedure (ASA 2023) | Oral semaglutide. |
| Mounjaro | Tirzepatide | Weekly injection | 1 week before (ASA 2023 and ASGE 2025) | GLP-1 / GIP dual mechanism. |
| Zepbound | Tirzepatide | Weekly injection | 1 week before (ASA 2023 and ASGE 2025) | Same active ingredient as Mounjaro. |
| Trulicity | Dulaglutide | Weekly injection | 1 week before (ASA 2023 and ASGE 2025) | |
| Victoza | Liraglutide | Daily injection | At least 24 hr before (ASGE 2025) or day of procedure (ASA 2023) | |
| Saxenda | Liraglutide | Daily injection | At least 24 hr before (ASGE 2025) or day of procedure (ASA 2023) | Weight-management dosing. |
| Byetta | Exenatide | Twice daily | At least 24 hr before (ASGE 2025) or day of procedure (ASA 2023) | |
| Bydureon BCise | Exenatide ER | Weekly injection | 1 week before (ASA 2023 and ASGE 2025) | |
| Adlyxin | Lixisenatide | Daily injection | At least 24 hr before (ASGE 2025) or day of procedure (ASA 2023) | |
| Foundayo | Orforglipron | Daily oral tablet | At least 24 hr before (ASGE 2025) or day of procedure (ASA 2023) | FDA-approved Apr. 1, 2026. Society guidance specifically naming orforglipron is limited; confirm with prescribing clinician and endoscopy center. |
| Compounded semaglutide or tirzepatide | Varies | Varies | Apply facility’s GLP-1 policy based on active ingredient, route, dose, and schedule | Disclose the active ingredient — not just the bottle label. |
Amber rows = weekly medications. These carry a 1-week hold under both ASA and ASGE guidance if a hold is chosen.
Compounded GLP-1s should be disclosed by active ingredient. Tell your GI office and anesthesiologist what is actually in the syringe (semaglutide, tirzepatide, or another GLP-1/GIP compound), the dose, the route, and the dosing schedule.
Don't double up after a missed weekly dose. If you held a weekly injection, ask the prescriber when to restart — not the GI office.
Are You in the Higher-Risk Group? The 5 Factors from the 2024 Guidance
The October 2024 multi-society guidance defines five variables that put a patient at elevated risk of delayed gastric emptying and aspiration. If one or more describes you, the team is more likely to recommend a 24-hour clear liquid diet, an anesthesia plan change, or a hold.
| Risk factor | What it means in plain language | What to watch for |
|---|---|---|
| Dose escalation phase | You’re still ramping up the dose | You started a new dose in the last 4–8 weeks |
| Higher dose | At or near the maximum dose for your medication | Wegovy 2.4 mg weekly, Wegovy HD 7.2 mg weekly, tirzepatide 15 mg weekly |
| Weekly dosing | Once-weekly injectables carry more GI side effects than daily formulations | Ozempic, Wegovy Pen, Mounjaro, Zepbound, Trulicity, Bydureon |
| Current GI symptoms | Active signs that your stomach is emptying slowly right now | Nausea, vomiting, abdominal pain, dyspepsia, prolonged fullness, constipation |
| Other gastric-emptying conditions | Comorbidities that independently slow stomach emptying | Gastroparesis, bowel dysmotility, Parkinson’s disease, prior gastric surgery |
None of these apply?
You are most likely in the “continue with appropriate precautions” group under current consensus guidance.
Two or more apply?
Call the GI office early. You need a more deliberate plan than a generic prep packet provides — not panic, but a real conversation.
What If You Already Took Your GLP-1 Before Colonoscopy?
The single most important rule on this page
Tell your care team you take a GLP-1 even if your prep packet didn't ask. Don't hide it, don't panic, and don't cancel the procedure on your own. Call the endoscopy center as soon as possible.
If your facility instructed you to hold and you took it anyway:
- Call now, even if it’s after hours and you only get the on-call line. They’d much rather know in advance than find out at check-in.
- Don’t add an extra day of bowel prep on your own. Too much prep is its own risk — dehydration, electrolyte problems, and worse, especially if you have kidney disease or diabetes.
- Don’t stop a diabetes medication on your own. If you also take insulin or a sulfonylurea, holding the GLP-1 and switching to clear liquids can drop your blood sugar.
- Be prepared for one of several outcomes: proceed as planned, proceed with a “full stomach” anesthesia plan, modify the prep window, or reschedule. The decision is the anesthesiology team’s.
Use this exact script when you call
“I'm scheduled for a colonoscopy on [date]. I take [Ozempic / Wegovy / Mounjaro / Zepbound / etc.] at [dose] [daily / weekly], for [diabetes / weight loss / other]. My last dose was [date and time]. Your instructions said to hold it; I took it anyway. I [do / do not] have nausea, vomiting, bloating, or constipation right now. Should I continue prep, change something, talk to anesthesia, or reschedule?”
That paragraph is the entire phone call. Read it word for word if it helps.
How to Prep Your Bowel for Colonoscopy When You Take a GLP-1
Even though the largest 2026 meta-analysis didn't find a statistically significant increase in inadequate prep rates among GLP-1 users, individual studies and many gastroenterologists report worse prep in this group. Don't modify your prep on your own. Ask your GI office which adjustments they want for a GLP-1 user.
Should you start a low-residue or low-fiber diet earlier?
A low-residue diet is often started a few days before colonoscopy. For GLP-1 users with slower transit, your GI office may extend that window from 1–2 days to 3–5 days.
Should you use split-dose prep?
Split-dose means you drink half of the prep solution the evening before and the other half several hours before your procedure. It is widely considered the highest-quality prep approach. If your packet uses single-dose, ask whether split-dose makes more sense given your medication.
Should you do a 2-day prep?
Some centers use a 2-day prep for patients with constipation, prior poor prep, gastroparesis, or other risk factors. Don’t add this on your own — it’s not safer if you don’t need it. Ask.
How much should you drink during prep?
Hydration matters a lot. Bowel prep can dehydrate you fast, especially when GLP-1s are already suppressing thirst and appetite. Hit your prep volume target. If you have kidney disease or heart failure, follow the specific limits your team gave you.
What if the prep just isn’t working?
Call the on-call line before procedure day. Don’t add extra senna or magnesium citrate without instruction. Adding extra laxatives can dehydrate you, disrupt electrolytes, and — if you have diabetes — drop blood sugar dangerously. If the prep isn’t working, call. Don’t freelance.
Three Different Doctors. One Coordinated Plan.
GLP-1 medications before a colonoscopy involve three separate clinicians, each with a different priority. A safe plan is the result of coordinating all three. A confusing plan is what happens when only one of them is involved.
Bowel prep and cancellation policy
GI office & endoscopy center
Decides what your prep packet says, when to start prep, what to drink, whether to reschedule if you didn’t hold a dose, and what the colonoscopy itself looks like.
Sedation safety plan
Anesthesia team
Decides your sedation plan on the day of the procedure. They can adjust based on your last dose, your symptoms, and any reflux or gastroparesis history. If you didn’t hold the medication and your stomach feels full, they can switch to a “full stomach” approach.
Medication hold & glucose plan
Prescribing clinician
Decides whether holding the GLP-1 is safe given your underlying reason for taking it. For diabetes patients on a GLP-1 plus insulin or a sulfonylurea, holding can swing blood sugar. They also give you the missed-dose / restart instructions.
Questions to ask your GI office
- Do your colonoscopy instructions require holding GLP-1 medications, and do they distinguish between daily and weekly formulations?
- Does your office use the 2024 multi-society guidance, the ASGE 2025 position, or your own internal protocol for GLP-1 holds?
- If I’m on a stable maintenance dose with no GI symptoms, can I do a 24-hour clear liquid diet instead of holding?
- Should I do a low-residue diet for longer or use a 2-day prep because I take a GLP-1?
- What should I do if my prep doesn’t look clear by the night before?
- If I already took my dose, will the procedure be canceled?
Questions to ask the anesthesia team
- Does my GLP-1 use change my sedation plan?
- Do my current symptoms suggest delayed gastric emptying?
- Does this matter more if I’m also having an upper endoscopy?
- If I didn’t hold the medication, can you still proceed safely?
- Will you use point-of-care gastric ultrasound if there’s a question about residual stomach contents?
Questions to ask your prescribing clinician
- Is it safe for me to hold this GLP-1 for [X] days?
- Do I need a glucose monitoring plan during the hold and the prep?
- Should any of my other diabetes medications change while I’m on clear liquids?
- When should I restart, and what should I do about the dose I missed?
- What should I do if I have a hypoglycemia episode during prep?
Printable one-page worksheet (write the answers by hand so they don't get lost in text messages)
When to Restart Your GLP-1 After Colonoscopy
Most patients can resume their GLP-1 after the procedure when they're eating and drinking normally — typically the day after for daily medications, or the next regularly scheduled dose for weekly medications. Restart timing should be confirmed by the prescribing clinician.
Weekly medication, held for a week
Most prescribers will tell you to take the next regularly scheduled dose on its normal day rather than catching up early. Do not double up.
Daily medication, held the day of the procedure
Most prescribers will tell you to resume the next day at the usual time, assuming you’re eating and drinking normally.
You had a polyp removed (polypectomy)
Some patients are asked to follow a soft or restricted diet for 24–72 hours. Ask the prescriber when to restart.
You had nausea, vomiting, or trouble keeping fluids down after the procedure
Wait until those symptoms resolve before restarting. Reintroducing a GLP-1 on top of unresolved nausea isn’t worth a single dose.
You take a sulfonylurea or insulin for diabetes
Restarting the GLP-1 after a few days of clear liquids and a missed dose can cause glucose to swing. Plan to monitor more closely for 24–48 hours after restarting.
Missed-dose rules by medication label
From current FDA prescribing information. Use as a starting point and confirm with your prescriber before acting.
| Brand | Form | Label missed-dose rule | What to ask after colonoscopy |
|---|---|---|---|
| Ozempic | Weekly injection | If next scheduled dose is more than 2 days (>48 hr) away, take missed dose ASAP. If 2 days or less, skip and take the next regular dose. | "When should I take my next dose — original schedule or shifted?" |
| Wegovy Pen | Weekly injection | Same as Ozempic — the >48-hour rule applies. | Same as Ozempic. |
| Wegovy Pill | Daily oral tablet | Skip the missed dose and take the next dose at the usual time. Do not double up. | "Do you want me to resume tomorrow morning at 25 mg?" |
| Rybelsus | Daily oral tablet | Skip the missed dose and take the next dose at the usual time. Do not double up. Take on an empty stomach with up to 4 oz of water. | "When and how should I take it tomorrow?" |
| Mounjaro | Weekly injection | Take the missed dose within 4 days. If more than 4 days have passed, skip it and resume the regular schedule. | "Am I within the 4-day window?" |
| Zepbound | Weekly injection | Same as Mounjaro — 4-day catch-up window. | Same as Mounjaro. |
| Trulicity | Weekly injection | Take within 3 days of the missed dose. If more than 3 days have passed, skip it. | "Am I within the 3-day window?" |
| Foundayo | Daily oral tablet | For once-daily oral GLP-1s, skip the missed dose and resume at the usual time. Confirm with prescriber. | "When should I resume?" |
Special Situations: Urgent Colonoscopy, Diabetes, and Combined Upper Endoscopy
Urgent or time-sensitive colonoscopy
If your colonoscopy was scheduled because of rectal bleeding, iron-deficiency anemia, a positive stool test (FIT, Cologuard, etc.), unexplained weight loss, or a known precancerous lesion, ask your team to weigh the medication risk against the risk of delaying the procedure. Pushing a diagnostic colonoscopy back several weeks to accommodate a medication hold may not be the right call.
Diabetes — the part most internet pages skip
If you take a GLP-1 for diabetes, the conversation isn't just “hold or continue.” It's also “what happens to my blood sugar during prep?”
- A clear liquid diet for 24 hours dramatically reduces carbohydrate intake.
- Standard fasting before the procedure removes them entirely.
- If you also take insulin or a sulfonylurea (glipizide, glyburide, or glimepiride), those medications continue to lower blood sugar — but now there’s much less food to balance them.
- The result can be hypoglycemia severe enough to cancel the procedure.
Ask the prescribing clinician for a specific plan: which doses to skip or reduce, how often to check your blood sugar, what number to call if it drops, and what to do if you feel symptoms during prep.
Combined colonoscopy plus upper endoscopy (EGD)
Some patients have a colonoscopy and an upper endoscopy on the same day. The upper endoscopy involves passing a scope into the stomach and small intestine, making residual gastric contents a more direct issue than in colonoscopy alone.
The 2026 OCULUS randomized clinical trial in JAMA Internal Medicine compared holding versus continuing GLP-1/GIP medications before upper endoscopy. Continuing was associated with higher rates of clinically significant residual gastric volume. In the 25-patient subgroup having a colonoscopy plus EGD with bowel prep and clear liquids, no clinically significant residual gastric volume was reported and no aspiration events occurred — but that subgroup is small. The finding is reassuring, not definitive.
If you're having both procedures on the same day, the conversation with anesthesia matters more, not less. Make sure they know which GLP-1 you're on and when your last dose was.
What the Evidence Actually Shows
The evidence on GLP-1s and colonoscopy outcomes is mixed and still developing. The honest read: the risks are real enough to warrant a thoughtful plan and not so dramatic that they should panic anyone into stopping a working medication without their prescriber's help.
Bowel prep evidence
| Source type | Study | Year | Population | Finding |
|---|---|---|---|---|
| Independent study | Nasser et al., JAMA Network Open | 2024 | Single-center cohort of GLP-1 users vs. controls | Inadequate prep: 21.3% GLP-1 users vs. 6.5% controls. No aspiration events. |
| Multi-site cohort + society commentary | Mayo Clinic / Gala et al., ASGE Journal Scan | 2025 | 3,344 GLP-1 users vs. 2,891 controls across 22 endoscopy units | Inadequate prep: 26.4% vs. 18.7%. ASGE: additional prep may be reasonable; optimal hold period unknown. |
| Meta-analysis | Chiu et al., Digestive and Liver Disease | 2025 | Six trials | Higher inadequate-prep risk and lower BBPS scores in GLP-1 users. |
| Meta-analysis (largest) | Ahmed et al., Gastrointestinal Endoscopy | 2026 | Six studies, 116,174 patients | No statistically significant pooled increase in inadequate prep. Slightly lower mean BBPS. Authors do not recommend discontinuing GLP-1 RAs before colonoscopy. |
Aspiration evidence
| Source | Finding |
|---|---|
| FDA / DailyMed labels (Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound) | Postmarketing reports of pulmonary aspiration during procedures requiring general anesthesia or deep sedation. Insufficient evidence to determine whether holding the drug or modifying fasting reduces risk. |
| OCULUS RCT, JAMA Internal Medicine 2026 | In upper endoscopy, continuing GLP-1/GIP was associated with higher residual gastric volume than holding. In the 25-patient combined EGD + colonoscopy subgroup with bowel prep and clear liquids, no clinically significant residual volume and no aspiration events reported. |
| Major bowel prep studies (Nasser, Gala, Ahmed, Chiu) | Aspiration events were rare or absent in reported colonoscopy series. |
None of these studies prove that holding a GLP-1 fixes bowel prep quality — they only describe what happened in patients who continued it. That is an important distinction when you're weighing whether a hold is worth a missed dose.
GLP-1 Colonoscopy Mistakes to Avoid
Not telling the anesthesia team you take a GLP-1. This is the single biggest mistake. Disclosure changes their plan if it needs changing. Hiding it doesn’t make the medication leave your body faster.
Assuming a smaller appetite means an empty stomach. GLP-1s reduce hunger. They don’t accelerate gastric emptying. Plenty of patients eat a normal-volume meal the night before prep and don’t realize their stomach is still working through it.
Following a 2023-era prep packet without confirming. If your packet says “hold for 1–2 weeks” and your prescriber says something different, call the GI office and ask which guidance they’re using and why. Get a clear answer.
Skipping hydration during prep. Especially relevant when GLP-1s are already suppressing thirst and appetite. Hit your prep volume target. Dehydration can become a bigger problem than poor prep.
Stopping a diabetes medication on your own. A GLP-1 hold combined with clear liquids and an unchanged sulfonylurea or insulin dose can drop blood sugar dangerously. Talk to the prescriber first.
Adding extra laxative when prep seems slow. Call the on-call line. They have an escalation plan. You don’t.
Restarting too aggressively after a missed weekly dose. Don’t double up. Take the next scheduled dose unless your prescriber tells you otherwise.
A 5-Factor Decision Framework You Can Use Today
The decision isn't binary. Walk through five factors and you'll know which clinician owns the next conversation. If two or more factors land in the higher-concern column, treat the prep call like a real medical visit, not a check-the-box phone call.
| Factor | Lower concern | Higher concern | Who to call |
|---|---|---|---|
| Facility policy | Your prep packet has clear, current instructions | Your packet doesn’t mention GLP-1s, contradicts your prescriber, or is from a strict 2023-era hold protocol | GI office or endoscopy center |
| Medication timing | Daily medication with clear instructions | Weekly medication with the procedure within the next 7 days, or you already took a dose against instructions | GI office or endoscopy center |
| Current symptoms | No nausea, vomiting, bloating, abdominal pain, or severe constipation | Active GI symptoms suggesting delayed gastric emptying, or known gastroparesis | GI office and anesthesia |
| Prep quality risk | No history of poor prep, no constipation, no recent dose escalation | Prior inadequate prep, current constipation, recent dose increase, weekly medication | GI office |
| Diabetes safety | GLP-1 for weight loss only, no other diabetes medications | GLP-1 for diabetes, especially with insulin or sulfonylurea | Prescribing clinician |
Frequently Asked Questions
- Do I need to stop Ozempic before a colonoscopy?
- Maybe — and the answer depends on your facility, your symptoms, and your dose. Under the October 2024 multi-society guidance, most adults on a stable dose of Ozempic can continue with a 24-hour clear liquid diet before an elective colonoscopy. ASGE’s 2025 position statement and many endoscopy centers still recommend holding weekly Ozempic for 7 days before the procedure. Follow your prep packet and call the facility if you have questions.
- When should I stop Wegovy before colonoscopy?
- If your facility uses a hold policy, the weekly Wegovy injection is typically held 7 days before the procedure, while the daily Wegovy pill is typically held the day before / at least 24 hours before under ASGE 2025, or skipped the day of under ASA 2023. If your facility follows the 2024 multi-society guidance and you’re on a stable dose with no GI symptoms, you may be allowed to continue with a 24-hour clear liquid diet. Confirm with the endoscopy center.
- Do I need to stop Mounjaro or Zepbound before colonoscopy?
- Mounjaro and Zepbound both contain tirzepatide, a once-weekly GLP-1/GIP medication. Their FDA labels include warnings about delayed gastric emptying and rare postmarketing reports of pulmonary aspiration during procedures requiring general anesthesia or deep sedation. Hold timing is the same as for other weekly GLP-1s — 1 week before the procedure if a hold is chosen — and the same risk-based individualization applies under current 2024 multi-society guidance.
- What if I took my GLP-1 within 7 days of colonoscopy?
- Call the endoscopy center. Don’t hide it and don’t cancel the procedure on your own. Some procedures can still proceed with appropriate precautions if you have no GI symptoms and followed standard fasting; the facility and anesthesia team make that call.
- Does GLP-1 use make colonoscopy prep fail?
- Sometimes, but not always. Studies show inadequate bowel prep in roughly 21–26% of GLP-1 users in some single-site and multi-site cohorts, compared to 6–19% in controls. The largest 2026 meta-analysis in Gastrointestinal Endoscopy did not find a statistically significant pooled increase in inadequate prep. Ask your GI office whether your prep packet should be modified for a GLP-1 user, especially if you have constipation or a history of poor prep.
- Should I do a 2-day colonoscopy prep because I take Ozempic?
- Only if your GI office recommends it. A 2-day prep is sometimes used for patients with constipation, gastroparesis, prior poor prep, or other risk factors. It is not a default for all GLP-1 users. Ask before adding extra prep on your own — too much prep is its own risk.
- Can I take Rybelsus the morning of my colonoscopy?
- Rybelsus is daily oral semaglutide. ASGE’s 2025 position recommends holding oral semaglutide the day before the procedure (at least 24 hours before). The older ASA 2023 default was to skip only the morning dose. Either way, confirm with your facility and your prescribing clinician.
- Do compounded semaglutide and tirzepatide follow the same hold timing?
- Treat a compounded product as relevant if it contains semaglutide, tirzepatide, or another GLP-1/GLP-1+GIP ingredient. Disclose the active ingredient, dose, route, and dosing schedule to your GI office and anesthesiologist. Do not assume a compounded product is interchangeable with the FDA-approved brand-name version. The FDA has warned about dosing errors, adverse events, and compounded products that use semaglutide salt forms — which the FDA describes as different active ingredients from those used in approved drugs.
- When can I take my next GLP-1 dose after the colonoscopy?
- Most patients can resume their GLP-1 the day after the procedure for daily medications, or at the next regularly scheduled weekly dose for weekly medications, assuming they’re eating and drinking normally. Specific catch-up windows differ by product — Ozempic and Wegovy use a >48-hour rule, Mounjaro and Zepbound use a 4-day window, Trulicity uses a 3-day window — so check the missed-dose rules table on this page and confirm with your prescriber.
- Will my insurance still cover my next GLP-1 dose if I skip a week for the procedure?
- Skipping a dose for a procedure does not automatically cancel the prescription, but coverage, refill timing, shipment schedule, and prior-authorization rules depend on your plan, pharmacy, and prescriber. If a missed dose could affect your refill timing, contact your pharmacy, insurer, or telehealth provider before the procedure.
- My GI office said hold for 2 weeks. Is that right?
- A 2-week hold is stricter than the 1-week recommendation for weekly GLP-1s under either the 2023 ASA guidance or the 2025 ASGE position. Some practices use a 2-week hold for higher-risk patients or for combined upper endoscopy and colonoscopy. Ask your GI office to explain why they’re recommending 2 weeks specifically. If holding for 2 weeks raises concerns about your diabetes management or your weight-loss progress, talk to the prescribing clinician about a coordinated plan.
- Is GLP-1 aspiration during colonoscopy actually common?
- Available evidence suggests it is rare in colonoscopy specifically, especially when a clear liquid prep has been used. The FDA labels for major GLP-1 medications include postmarketing reports of pulmonary aspiration during procedures requiring general anesthesia or deep sedation, but the labels also state there is insufficient evidence to know whether holding the medication or modifying fasting reduces that risk. The 2024 multi-society guidance was written specifically to balance this rare risk against the harms of unnecessary medication holds.
Sources We Verified
- American Society of Anesthesiologists. Consensus-Based Guidance on Preoperative Management of Patients on GLP-1 Receptor Agonists. June 2023.
- AASLD/ACG/AGA/ASGE/NASPGHAN. GI Multi-Society Statement Regarding GLP-1 Agonists and Endoscopy. August 2023.
- American Gastroenterological Association. AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy. Clinical Gastroenterology and Hepatology. November 2023.
- Kindel TL, Wang AY, Wadhwa A, et al. Multi-Society Clinical Practice Guidance for the Safe Use of GLP-1 Receptor Agonists in the Perioperative Period. Co-published in Surgical Endoscopy, CGH, and SOARD. October 2024.
- American Society for Gastrointestinal Endoscopy. Position statement on periendoscopic management of patients on GLP-1 receptor agonists. 2025.
- Nasser AS, et al. Food Retention at Endoscopy Among Adults Using GLP-1 Receptor Agonists. JAMA Network Open. 2024.
- Mayo Clinic / Gala et al. Examining the impact of GLP-1 receptor agonist use on quality of bowel preparation for colonoscopy. Multi-site cohort. 2025.
- ASGE Journal Scan. GLP-1 Receptor Agonists Negatively Impact Bowel Preparation for Colonoscopy. 2025.
- Ahmed Z, Iqbal A, Arif SF, et al. Bowel preparation quality in patients using GLP-1 agonists: a systematic review and meta-analysis. Gastrointestinal Endoscopy. 2026;103(2):235–240.e5.
- Chiu Y-T, Chen Y-T, Lee F-J, et al. Impact of GLP-1 receptor agonists on colonoscopy quality: a systematic review and meta-analysis. Digestive and Liver Disease. 2025.
- OCULUS investigators. Holding vs Continuing GLP-1/GIP Agonists Before Upper Endoscopy: The OCULUS Randomized Clinical Trial. JAMA Internal Medicine. 2026.
- DailyMed (FDA prescribing information) for Ozempic, Wegovy injection and tablet, Rybelsus, Mounjaro, and Zepbound. Accessed May 2026.
- FDA. Approves First New Molecular Entity Under National Priority Voucher Program (Foundayo / orforglipron). Accessed May 2026.
- FDA. Approves Higher Dose Semaglutide (Wegovy HD 7.2 mg). March 2026.
- Novo Nordisk. FDA approval of oral Wegovy. December 2025.
- FDA. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Accessed May 2026.
A Few Honest Caveats Before You Go
Guidance can change. This page reflects the picture as of . We re-verify quarterly and stamp the page with the date so you can see how fresh it is. Next review: August 2026.
Compounded GLP-1s are not interchangeable with FDA-approved versions. Some are labeled as semaglutide or tirzepatide, but compounded drugs are not FDA-approved, and the FDA has warned about dosing errors, adverse events, and semaglutide salt forms that are different active ingredients from those used in approved drugs.
This page is not medical advice. It's a decision-support tool. Your GI office, anesthesiologist, and prescribing clinician are the ones who actually make the call.
If your colonoscopy is in the next 7 days and you take a weekly GLP-1, stop reading and call the endoscopy center. The single most useful thing this page can do is push you toward that phone call before procedure day, not after.